Last reviewed · How we verify

NCT04163497

ICU Diaries and Its Effects After the Unit Discharge

Status unknown NA Last updated 14 November 2019
What this trial tests

NA trial testing ICU Diaries in Post Intensive Care Unit Syndrome in 102 participants. Status unknown.

Timeline
22 July 2019
Primary endpoint
9 March 2020
9 September 2020

Quick facts

Lead sponsorHospital Ernesto Dornelles
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingsingle
Primary purposeprevention
Enrollment102
Start date22 July 2019
Primary completion9 March 2020
Estimated completion9 September 2020
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Hospital Ernesto Dornelles

Who can join

18 and older, any sex, with Post Intensive Care Unit Syndrome or Intensive Care Unit Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The preparation of ICU Diary, conducted by the Hospital care team towards the patient, has been suggested as an effective and low-cost strategy to enhance the patient's experience in the intensive care unit, as well as to prevent anxiety, depression and Posttraumatic Stress Disorder (PTSD). New-found researches in Brazilian ICUs indicates the pervasiveness of these symptoms in patients who have been hospitalized in the unit, however, there are no randomized trials that evaluate the impact of Diaries in the Brazilian context. The aim is to explore the effects of providing an ICU Diary in the symptoms of anxiety, depression and PTSD within patients who were hospitalized in the unit. Refers to a randomized controlled trial that is being conducted in two ICUs in a general-purpose hospital in Porto Alegre, Brazil.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Post Intensive Care Unit Syndrome

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04163497.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing